Atlas Trials

Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation

Clinical trial NCT04830462 · COMPLETED

Trial details

NCT number
NCT04830462
Sponsor
Herlev and Gentofte Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Latent TuberculosisDiabetes Mellitus, Type 2
Start date
2021-04-15
Primary completion
2023-05-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.